Peer Review reports
From: Efficacy of Episil® in patients with hematologic malignancies: a comparative study
| Original Submission | ||
|---|---|---|
| 18 Jul 2023 | Submitted | Original manuscript |
| 24 Aug 2023 | Reviewed | Reviewer Report - Anncarin Svanberg |
| 26 Aug 2023 | Reviewed | Reviewer Report |
| 30 Sep 2023 | Author responded | Author comments - Taeko Fukutani |
| Resubmission - Version 2 | ||
| 30 Sep 2023 | Submitted | Manuscript version 2 |
| 14 Jan 2024 | Reviewed | Reviewer Report |
| 2 Feb 2024 | Author responded | Author comments - Taeko Fukutani |
| Resubmission - Version 3 | ||
| 2 Feb 2024 | Submitted | Manuscript version 3 |
| 15 Mar 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 8 Apr 2024 | Editorially accepted | |
| 3 May 2024 | Article published | 10.1186/s12903-024-04233-6 |
You can find further information about peer review here.